MMATISS brings a strong foundation of experience to the design and execution of specialized Clinical Trials.
The specialized MMATISS team is ready to help validate clinical or safety hypotheses. MMATISS is able to process efficiently high volumes of case report forms generated by high-enrollment studies.
MMATISS delivers the insight and expertise of scientists, physicians, regulators, with competences that cover each and every aspect of the drug development process. In 2001 alone, MMATISS Phase II-IV comprehensive services were delivered globally across multiple therapeutic specialties, at a total of approximately 328 active study sites.
MMATISS takes innovative approaches to provide clean, high-quality data that are generated on time and within budget, by challenging assumptions about traditional clinical trial design and management. MMATISS CRO group offices share global SOPs, communication systems, and the high standards of quality that ensure excellence in these efforts.